Lidocaine 5% medicated plaster

DRUG5 trials

Sponsors

Grünenthal GmbH, University Hospital, Clermont-Ferrand

Conditions

Chronic PainNeuropathic PainOsteoporotic Vertebral FracturePainPost Herpetic NeuralgiaPostoperative Pain

Phase 2

Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain

TerminatedNCT01155986

Grünenthal GmbHChronic Pain, Neuropathic Pain, Pain +1

Start: 2010-08-31End: 2012-11-30Updated: 2019-10-16

Phase 3

Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain

CompletedNCT01752322

Grünenthal GmbHChronic Pain, Neuropathic Pain, Pain +1

Start: 2012-10-31End: 2016-06-30Updated: 2016-07-06

A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)

CompletedNCT03745404

Grünenthal GmbHPost Herpetic Neuralgia

Start: 2003-04-29End: 2004-06-30Updated: 2023-09-13

A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia

CompletedNCT03765697

Grünenthal GmbHPost Herpetic Neuralgia

Start: 2003-07-16End: 2009-02-12Updated: 2023-09-13

Phase 4

Osteoporotic Fracture and Lidocaine Plaster 5% for Neuropathic Pain preventioN

Not yet recruitingNCT07691359

University Hospital, Clermont-FerrandNeuropathic Pain, Osteoporotic Vertebral Fracture

Start: 2026-07-01End: 2028-10-01Target: 30Updated: 2026-07-08

Related Papers

Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial.

2019-01-2115 citations